Unlocking Access to HCV Testing in Jail: Stakeholder Involvement in Research Is the Missing Key

解锁监狱中 HCV 检测的机会:利益相关者参与研究是缺失的关键

基本信息

  • 批准号:
    10381496
  • 负责人:
  • 金额:
    $ 15.01万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-05-01 至 2023-04-30
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract About 3 million people in the US are living with hepatitis C virus infection (HCV), and the burden of HCV is highly concentrated in incarcerated populations. Curative HCV treatment is available, but infrequently available in corrections settings. There are disparities in access to HCV care between White and Non-White people in the community, and non-White people have higher rates of incarceration. As a result, liver disease is one of the leading causes of death in inmates, especially Non-White inmates. One feasible approach to overcoming health disparities for HCV care in incarcerated populations is increasing the diagnosis of HCV. This approach is particularly pragmatic for the jailed population—people incarcerated for less than 2.5 years—with linkage to HCV treatment arranged post-release. Opt-out infectious disease testing both increases overall frequency of testing and decreases racial disparities in testing. Unlike opt-in testing, which requires explicit agreement to perform testing, opt-out testing informs individuals that they will be tested unless they decline. Opt-out HCV testing in prisons is recommended by federal policy, and recently mandated in all Massachusetts (MA) prisons through a court ruling. Opt-out testing is not mandated in MA jails. The overarching goal of my research proposal is improving access to HCV testing in jails with the ultimate aim of reducing the prevalence of HCV in the US. The first aim of this research proposal is a comparison of current HCV testing practices to testing policy through retrospective chart review with a focus on racial disparities in access to testing. The second aim is a hybrid effectiveness-implementation aim with the goal of implementing opt-out HCV testing and evaluating effectiveness of opt-out testing to increase testing frequency and decrease racial disparities in HCV testing. Imbedded in the research activities is a robust training plan including advanced epidemiology and implementation science methodology. Support of key stakeholders has been confirmed, including representatives from the criminal justice system, health care providers in the jail, and the MA public health department. Augmented by training in innovative and synergistic methodologic disciplines, completion of this research proposal will be the foundation for a successful research career devoted to using implementation science methodology to improve the quality and equity of health care provided in corrections settings.
项目摘要/摘要 美国约有300万人患有丙型肝炎病毒(丙型肝炎病毒), 丙型肝炎病毒的负担高度集中在被监禁人口中。治疗丙型肝炎的治疗法是 可用,但在更正设置中很少可用。在获取信息方面存在差距 社区中白人和非白人之间以及非白人之间的丙型肝炎病毒关怀 更高的监禁率。因此,肝病是#年导致死亡的主要原因之一。 囚犯,尤其是非白人囚犯。 克服狱中丙型肝炎患者健康差距的一种可行方法 人群正在增加对丙型肝炎病毒的诊断。这种方法对于 被监禁人口-监禁时间不到2.5年的人-与丙型肝炎病毒治疗有关 安排在释放后。选择退出传染病检测既增加了总的发病率 测试和减少测试中的种族差异。与选择加入测试不同,选择加入测试需要显式 同意进行测试,选择退出测试通知个人他们将接受测试,除非 他们拒绝了。联邦政策建议在监狱进行丙型肝炎病毒检测,最近 通过法院裁决在所有马萨诸塞州(MA)监狱强制执行。选择退出测试不是 在马萨诸塞州监狱强制执行。 我的研究提案的首要目标是改善监狱中接受丙型肝炎病毒检测的机会 最终目的是降低丙型肝炎病毒在美国的流行率。这项研究的首要目的是 建议是通过回顾将当前的丙型肝炎病毒检测实践与检测政策进行比较 图表审查,重点放在获得检测方面的种族差异。第二个目标是混合动力车 有效性-实施目标是实施选择退出丙型肝炎病毒检测和 评估选择退出测试的有效性,以增加测试频率和减少种族 丙型肝炎病毒检测中的差异。在研究活动中嵌入了一个强有力的培训计划,包括 高级流行病学和实施科学方法论。关键利益攸关方的支持 已经得到确认,包括来自刑事司法系统、医疗保健 监狱里的提供者和马萨诸塞州公共卫生部门。通过创新培训来增强 和协同方法论学科,完成这项研究提案将是 致力于使用实现科学的成功研究事业的基础 改进惩教环境中提供的卫生保健的质量和公平的方法。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Racial differences in testing for infectious diseases: An analysis of jail intake data.
  • DOI:
    10.1371/journal.pone.0288254
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
  • 通讯作者:
Hepatitis C Virus Is Associated With Increased Mortality Among Incarcerated Hospitalized Persons in Massachusetts.
丙型肝炎病毒与马萨诸塞州被监禁的住院医师中的死亡率增加有关。
  • DOI:
    10.1093/ofid/ofab579
  • 发表时间:
    2021-12
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    Wurcel AG;Guardado R;Beckwith CG
  • 通讯作者:
    Beckwith CG
Implementation of a bundle to improve HIV testing during hospitalization for people who inject drugs.
  • DOI:
    10.1177/26334895231203410
  • 发表时间:
    2023-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Grussing, Emily D.;Pickard, Bridget;Khalid, Ayesha;Smyth, Emma;Childs, Victoria;Zubiago, Julia;Nunez, Hector;Jung, Amanda;Morales, Yoelkys;Daudelin, Denise H.;Wurcel, Alysse G.
  • 通讯作者:
    Wurcel, Alysse G.
Heterogeneity in Jail Nursing Medical Intake Forms: A Content Analysis.
Variation by Race in Antibiotics Prescribed for Hospitalized Patients With Skin and Soft Tissue Infections.
  • DOI:
    10.1001/jamanetworkopen.2021.40798
  • 发表时间:
    2021-12-01
  • 期刊:
  • 影响因子:
    13.8
  • 作者:
    Wurcel AG;Essien UR;Ortiz C;Fu X;Mancini C;Zhang Y;Blumenthal KG
  • 通讯作者:
    Blumenthal KG
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Alysse Gail Wurcel其他文献

Alysse Gail Wurcel的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Alysse Gail Wurcel', 18)}}的其他基金

Unlocking Access to HCV Testing in Jail: Stakeholder Involvement in Research Is the Missing Key
解锁监狱中 HCV 检测的机会:利益相关者参与研究是缺失的关键
  • 批准号:
    9977343
  • 财政年份:
    2020
  • 资助金额:
    $ 15.01万
  • 项目类别:
Unlocking Access to HCV Testing in Jail: Stakeholder Involvement in Research Is the Missing Key
解锁监狱中 HCV 检测的机会:利益相关者参与研究是缺失的关键
  • 批准号:
    10112951
  • 财政年份:
    2020
  • 资助金额:
    $ 15.01万
  • 项目类别:

相似海外基金

Contributing to Hepatitis C Virus (HCV) Eradication in Canada: An Implementation Science-based Approach to Promoting Equitable Access to HCV Care for People Who Inject Drugs
为加拿大根除丙型肝炎病毒 (HCV) 做出贡献:以科学为基础的实施方法,促进注射吸毒者公平获得 HCV 护理
  • 批准号:
    440211
  • 财政年份:
    2020
  • 资助金额:
    $ 15.01万
  • 项目类别:
    Fellowship Programs
Unlocking Access to HCV Testing in Jail: Stakeholder Involvement in Research Is the Missing Key
解锁监狱中 HCV 检测的机会:利益相关者参与研究是缺失的关键
  • 批准号:
    9977343
  • 财政年份:
    2020
  • 资助金额:
    $ 15.01万
  • 项目类别:
Contributing to Hepatitis C Virus (HCV) Eradication in Canada: An Implementation Science-based Approach to Promoting Equitable Access to HCV Care for People Who Inject Drugs
为加拿大根除丙型肝炎病毒 (HCV) 做出贡献:以科学为基础的实施方法,促进注射吸毒者公平获得 HCV 护理
  • 批准号:
    436172
  • 财政年份:
    2020
  • 资助金额:
    $ 15.01万
  • 项目类别:
    Fellowship Programs
Unlocking Access to HCV Testing in Jail: Stakeholder Involvement in Research Is the Missing Key
解锁监狱中 HCV 检测的机会:利益相关者参与研究是缺失的关键
  • 批准号:
    10112951
  • 财政年份:
    2020
  • 资助金额:
    $ 15.01万
  • 项目类别:
RCT of a social-network oriented mhealth based intervention to increase access and adherence to HCV treatment and HIV viral suppression
基于社交网络的移动健康干预措施的随机对照试验,以提高丙肝治疗和艾滋病病毒抑制的可及性和依从性
  • 批准号:
    9883765
  • 财政年份:
    2015
  • 资助金额:
    $ 15.01万
  • 项目类别:
Applying the Gelberg-Andersen Behavioral Health Model to assess correlates of primary care access among HIV- and HCV-seronegative persons who inject drugs
应用 Gelberg-Andersen 行为健康模型评估 HIV 和 HCV 血清阴性注射吸毒者获得初级保健的相关性
  • 批准号:
    294392
  • 财政年份:
    2013
  • 资助金额:
    $ 15.01万
  • 项目类别:
Reduce Transmission Risks & Improve HCV Treatment Access
降低传播风险
  • 批准号:
    6661191
  • 财政年份:
    2001
  • 资助金额:
    $ 15.01万
  • 项目类别:
Reduce Transmission Risks & Improve HCV Treatment Access
降低传播风险
  • 批准号:
    6408905
  • 财政年份:
    2001
  • 资助金额:
    $ 15.01万
  • 项目类别:
Reduce Transmission Risks & Improve HCV Treatment Access
降低传播风险
  • 批准号:
    6800373
  • 财政年份:
    2001
  • 资助金额:
    $ 15.01万
  • 项目类别:
IDU Access to HIV/HCV Prevention
注射吸毒者获得艾滋病毒/丙型肝炎预防
  • 批准号:
    6660272
  • 财政年份:
    2001
  • 资助金额:
    $ 15.01万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了